首页> 美国卫生研究院文献>Journal of the Boston Society of Medical Sciences >Genetic and Epigenetic Modification of MLH1 Accounts for a Major Share of Microsatellite-Unstable Colorectal Cancers
【2h】

Genetic and Epigenetic Modification of MLH1 Accounts for a Major Share of Microsatellite-Unstable Colorectal Cancers

机译:MLH1的遗传和表观遗传修饰占微卫星不稳定结直肠癌的主要份额。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Microsatellite instability (MSI) is a hallmark of hereditary nonpolyposis colorectal cancer, and in these patients, results from inherited defects in DNA mismatch repair genes, mostly MSH2 and MLH1. MSI also occurs in 15% of sporadic colorectal cancers, but in these tumors, its basis is less well characterized. We investigated 46 sporadic MSI+ colorectal cancers for changes in MSH2 and MLH1 protein expression, followed by the analysis of somatic mutation, loss of heterozygosity (LOH), and promoter hypermethylation as possible underlying defects. Most cases (36/46, 78%) showed lost or reduced MLH1 expression. Among these, a majority (83%) was associated with MLH1 promoter hypermethylation, whereas the rates of LOH and somatic mutation of MLH1 were 24% and 13%, respectively. Hypermethylation and LOH were inversely correlated, suggesting that they had alternative functions in the inactivation of MLH1. MSH2 expression was lost in 7/46 (15%), and of these, 2 (29%) showed LOH and/or somatic mutation of MSH2. We conclude that most sporadic MSI+ colorectal cancers have an MLH1-associated etiology and that epigenetic modification is a major mechanism of MLH1 inactivation. Moreover, we found a significantly lower prevalence for MLH1 promoter hypermethylation in hereditary nonpolyposis colorectal cancer tumors with MLH1 germline mutations (12/26, 46%), which might explain some differences that are known to occur in the clinicopathological characteristics and tumorigenic pathways between sporadic and hereditary MSI+ colorectal cancers.
机译:微卫星不稳定性(MSI)是遗传性非息肉性结直肠癌的标志,在这些患者中,是由DNA错配修复基因(主要是MSH2和MLH1)的遗传缺陷导致的。 MSI还发生在15%的散发性结直肠癌中,但在这些肿瘤中,其基础特征尚不明确。我们调查了46个散发的MSI +大肠癌中MSH2和MLH1蛋白表达的变化,然后分析了体​​细胞突变,杂合性缺失(LOH)和启动子超甲基化作为可能的潜在缺陷。大多数病例(36/46,78%)显示MLH1表达丢失或减少。其中,大多数(83%)与MLH1启动子甲基化有关,而MLH1的LOH和体细胞突变率分别为24%和13%。高甲基化和LOH呈负相关,表明它们在MLH1的失活中具有替代功能。 MSH2表达丢失了7/46(15%),其中2(29%)显示出LOH和/或MSH2的体细胞突变。我们得出的结论是,大多数零星的MSI +大肠癌都有MLH1相关病因,表观遗传修饰是MLH1失活的主要机制。此外,我们发现具有MLH1种系突变的遗传性非息肉病性大肠癌肿瘤中MLH1启动子高甲基化的发生率显着降低(12/26,46%),这可能解释了散发性之间的临床病理特征和致癌途径之间存在的某些差异和遗传性MSI +大肠癌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号